Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
Clinical trial NCT02120807 · COMPLETED
Trial details
- NCT number
- NCT02120807
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-15
- Primary completion
- 2023-01-24
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.